Wenyuan Liu, Hongli Yin, Zhiwei Xie, Fang Fang, Jinhua Chu, Linhai Yang, Lingling Huang, Songji Tu, Huaju Cai, Zhengyu Wu, Anbang Wei, Chengzhu Liu, Yi Hong, Xiaotong Tian, Yan Cheng, Jian Pan, Ningling Wang, Kunlong Zhang
Acute myeloid leukemia (AML) is a rare and heterogeneous disease. Over the past few decades, patient prognosis has improved with continuous improvements in treatment, but outcomes for some patients with primary drug resistance or relapse after treatment remain poor. Additional therapies to improve outcomes for these patients are urgently needed. FYB1 expression differs substantially between AML tissues and normal tissues. High FYB1 expression is correlated with poorer overall survival (OS), indicating that FYB1 may regulate AML progression...
May 3, 2024: Molecular and Cellular Biochemistry